Roche, Eli Lilly’s Alzheimer’s blood test gets FDA clearance

Roche, Eli Lilly’s Alzheimer’s blood test gets FDA clearance  CNN

The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer’s disease, marking the fourth time such a blood test has been approved in less than two years. Roche announced on Sunday that the FDA had granted approval to its Elecsys Phospho-Tau blood test for diagnosing Alzheimer’s disease. It

The Elecsys pTau217 test can help doctors assess amyloid pathology in people 55 and older showing signs of cognitive decline

The nod follows European approval for the Elecsys pTau217 test in May.

The U.S. Food and Drug Administration (FDA) has cleared Roche and partner Eli Lilly’s blood test to help identify signs of Alzheimer’s disease in people aged 55 and older with cognitive decline.

FDA Clears Roche And Eli Lilly’s Alzheimer’s Blood Test  Forbes

Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance  Reuters

FDA Approves Alzheimer’s Blood Test Developed by Roche and Eli Lilly  WSJ